Get started
Author

Maria del Monte

Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE
2005 · D. Alonso, I. Dorronsoro, et al. · Bioorganic & Medicinal Chemistry · 157
Abstract GS5-01: Residual cancer burden after neoadjuvant therapy and long-term survival outcomes in breast cancer: A multi-center pooled analysis
2020 · Christina Yau, Marieke van der Noordaa, et al. · Cancer Research · 26
Synthesis and Biological Evaluation of Tacrine‐Thiadiazolidinone Hybrids as Dual Acetylcholinesterase Inhibitors
2005 · Isabel Dorronsoro, Diana Alonso, et al. · Archiv der Pharmazie · 19
Small-cell carcinoma of the rectum
1985 · A. Robidoux, M. Monté, et al. · Diseases of the Colon & Rectum · 18
Hereditary breast cancer in 19 females and 2 males: Kindred, P.G. 1940
1995 · P. Ghadirian, S. Narod, et al. · European Journal of Cancer · 8
32P Immune T cell subsets dynamics in the early TNBC treatment setting
2024 · R. Martín Lozano, N. Jiménez-Alduán, et al. · Immuno-Oncology Technology
PDF
258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC)
2024 · C. Bueno Muiño, I. Echavarria Diaz-Guardamino, et al. · Annals of Oncology
PDF
Implication of MODEL of financing clinical research in breast cancer during the past two decades.
2016 · Yolanda Jerez, Sara Lopez-Tarruella, et al. · Journal of Clinical Oncology
Synthesis and Biological Evaluation of Tacrine‐Thiadiazolidinone Hybrids as Dual Acetylcholinesterase Inhibitors.
2005 · Isabel Dorronsoro, Diana Alonso, et al. · ChemInform
Works count: 9
Citation count: 228
H-index: 5
I10-index: 4
Year
Topic
Type